Media

Publications Photos Videos Documents Audio/Podcasts

Publications:

Documents:

Photos:

Videos:

Audio/Podcasts:

Social

Biography

James Carroll is Founder & CEO of THOR Photomedicine and an acknowledged world expert on the effect of light on cellular function. James' role is to develop the best possible light parameters for maximizing the effects from a wearable device.

Industry Expertise (1)

Medical Devices

Areas of Expertise (3)

Photomedicine

Lasets and Human Cellular Function

Wearable Devices

Education (1)

Harlow Technical College: Electronics

Media Appearances (3)

NovoTHOR, a ‘Star Trek-like’ Light Therapy for Mitochondria, Wins Innovation Award

Mitochondrial Disease News  

2016-07-15

According to a news release, THOR founder and CEO James Carroll likened the device to “something from Star Trek” in a presentation at the United Nations. “When somebody gets injured, they are taken to sick bay. The doctor gets out a laser beam, he aims it at the injury, and the patient is healed instantly,” Carroll said. “Well, we make those. It is not as instant as on TV, but you get the idea, you shine light on an injury and it heals more quickly.”

view more

"STAR TREK" Style Light Pod Wins Innovation of the Year

PR Newswire  

2016-06-30

In a presentation to the United Nations, THOR founder & CEO James Carroll described PBM treatment as being "like something from Star Trek...when somebody gets injured, they are taken to sick bay. The doctor gets out a laser beam, he aims it at the injury, and the patient is healed instantly. Well, we make those. It is not as instant as on TV, but you get the idea, you shine light on an injury and it heals more quickly"

view more

The Promise of Advanced Laser-Based Therapy

Photonics  

2014-08-01

Recent medical research theorizes that the mechanism of low-level laser therapy is primarily via the absorption of light within mitochondria, the numerous “power plants” within cells that convert the oxygen and pyruvate from food into cellular energy via adenosine triphosphate (ATP). As it happens, cytochrome C oxidase, a critical protein involved in the regulation of mitochondrial activity, is a photoacceptor of light in the near- to far-IR. At the cellular level, LLLT displaces nitric oxide from the respiratory chain to increase levels of ATP and reactive oxygen species. The deep-tissue application of laser or LED devices in LLLT techniques may work via this mitochondrial mechanism to promote tissue repair, reduce inflammation and induce analgesia, according to James Carroll, medical researcher, and founder and CEO of Thor Photomedicine in Chesham, England.

view more